A placebo-controlled trial of isoprinosine in patients with multiple sclerosis.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 7510330.
- Also identified by PMC identifier 1072442.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Isoprinosine was used under double-blind, randomised, and placebo-controlled conditions in 52 patients with relapsing/remitting or progressive multiple sclerosis. All patients received pulsed treatment with methylprednisolone. There was no significant effect of treatment on clinical disability or the accumulation of MRI abnormalities, after correction of results for multiple comparisons. It is concluded that isoprinosine is not effective therapy for multiple sclerosis.
Medical subject headings
- Inosine Pranobex
- Multiple Sclerosis